ACTOS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actos, and when can generic versions of Actos launch?
Actos is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in ACTOS is pioglitazone hydrochloride. There are twenty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the pioglitazone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actos
A generic version of ACTOS was approved as pioglitazone hydrochloride by CHARTWELL RX on October 26th, 2012.
Summary for ACTOS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 145 |
Patent Applications: | 3,944 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ACTOS |
Drug Sales Revenues: | Drug sales revenues for ACTOS |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ACTOS |
What excipients (inactive ingredients) are in ACTOS? | ACTOS excipients list |
DailyMed Link: | ACTOS at DailyMed |
US Patents and Regulatory Information for ACTOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-001 | Jul 15, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-002 | Jul 15, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-003 | Jul 15, 1999 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACTOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-003 | Jul 15, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-001 | Jul 15, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-002 | Jul 15, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-003 | Jul 15, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-003 | Jul 15, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | ACTOS | pioglitazone hydrochloride | TABLET;ORAL | 021073-001 | Jul 15, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACTOS
See the table below for patents covering ACTOS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Argentina | 061195 | COMPOSICION FARMACEUTICA PARA PROFILAXIS Y TRATAMIENTO DE LA DIABETES | ⤷ Try a Trial |
Slovakia | 287287 | ⤷ Try a Trial | |
Canada | 1277323 | DERIVES DE THIAZOLIDINEDIONE, LEUR PRODUCTION ET LEUR EMPLOI (THIAZOLIDINEDIONE DERIVATIVES, THEIR PRODUCTION AND USE) | ⤷ Try a Trial |
Russian Federation | 2198682 | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (PHARMACEUTICAL COMPOSITION) | ⤷ Try a Trial |
Japan | 2007191494 | MEDICINE | ⤷ Try a Trial |
South Africa | 8600203 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACTOS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1174135 | 437 | Finland | ⤷ Try a Trial | |
1174135 | SPC026/2009 | Ireland | ⤷ Try a Trial | SPC026/2009: 20101001, EXPIRES: 20210619 |
1174135 | C01174135/01 | Switzerland | ⤷ Try a Trial | FORMER REPRESENTATIVE: BOHEST AG, CH |
0861666 | 07C0006 | France | ⤷ Try a Trial | PRODUCT NAME: PIOGLITAZONE/METFORMINE ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/06/354/001 DU 20060728; REGISTRATION NO/DATE AT EEC: EU/1/06/354/001 DU 20060728 |
0193256 | C300038 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PIOGLITAZON, DESGEWENST IN DE VORM VAN EEN FARMACOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/00/151/001 - EU/1/00/151/006 20001011 |
0861666 | 291 | Finland | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |